Takeda Announces Positive Topline Results from Phase 2 Study Evaluating Mezagitamab (TAK-079), a Pot
2024-03-14 17:51:14Entravision Mobile Growth Solutions将其移动应用推广部门正式更名为Adwake
2024-03-14 17:49:34摩根智能指纹锁亮相2024德国法兰克Light+Building
2024-03-14 16:25:57随机文章